While our previous work has demonstrated proof-of-concept solutions, it lacked fundamental communication abstractions, a rigorous design, and a thorough analysis on the effectiveness of these solutions.
The present study has demonstrated proof-of-the-concept that esmolol + milrinone-induced Akt activation is dependent on PKA stimulation, since in the presence of PKA inhibition with Rp-cAMPS, milrinone + esmolol failed to activate Akt (Fig. 4).
The company issued a news release on July 25 proclaiming that the vaccine had "demonstrated proof of efficacy" in the trial, with details to be published in a medical journal.
Recent clinical data have demonstrated proof of mechanism and clinical benefit for antisense drugs in many disease areas including cancer.
Multiple vaccine strategies, mostly relying on virus-like particle antigens, are under development and have demonstrated proof of efficacy in human challenge studies.
Moreover, we have demonstrated proof of principle for using MNT as a platform for developing targeted short-range (α-particle) radiotherapeutic agents for cancer therapy [7].
Experiments conducted in our laboratory have demonstrated proof of this concept in GBM cells.
In this regard, a number of pharmaceutical companies have demonstrated proof of concept in preclinical trials using 11β-HSD1 inhibitors, with weight loss, improved glucose tolerance, and beneficial lipid profiles in diet-induced obese and diabetic mouse models (17– 20).
Having demonstrated proof of concept, future work will now focus on elucidating structure activity relationships, expanding the modeling work to look at conjugate membrane interactions, tracking metabolic fate, and determining specific cellular localization within the retina to identify therapeutic applicability.
We feel we have demonstrated proof of efficacy in a mouse tumour model of a novel HPV therapeutic vaccine candidate, which should be easy and cheap to produce and purify.
